These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2563304

  • 1. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF, Waszczak BL.
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [Abstract] [Full Text] [Related]

  • 2. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF, Waszczak BL.
    Brain Res; 1990 Nov 26; 534(1-2):273-82. PubMed ID: 1981482
    [Abstract] [Full Text] [Related]

  • 3. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
    Cox RF, Neumeyer JL, Waszczak BL.
    J Pharmacol Exp Ther; 1988 Oct 26; 247(1):355-62. PubMed ID: 3171980
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF, Waszczak BL.
    Brain Res; 1993 Jun 04; 613(1):32-42. PubMed ID: 8102308
    [Abstract] [Full Text] [Related]

  • 5. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M.
    Mol Pharmacol; 1987 Jun 04; 31(6):592-8. PubMed ID: 2885734
    [Abstract] [Full Text] [Related]

  • 6. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum.
    Enz A, Goldstein M, Meller E.
    Mol Pharmacol; 1990 Apr 04; 37(4):560-5. PubMed ID: 1970116
    [Abstract] [Full Text] [Related]

  • 7. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
    Meller E, Puza T, Miller JC, Friedhoff AJ, Schweitzer JW.
    J Pharmacol Exp Ther; 1991 May 04; 257(2):668-75. PubMed ID: 1674531
    [Abstract] [Full Text] [Related]

  • 8. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul 04; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
    Meller E, Puza T, Diamond J, Lieu HD, Bohmaker K.
    J Pharmacol Exp Ther; 1992 Nov 04; 263(2):462-9. PubMed ID: 1359107
    [Abstract] [Full Text] [Related]

  • 10. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
    Adham N, Ellerbrock B, Hartig P, Weinshank RL, Branchek T.
    Mol Pharmacol; 1993 Mar 04; 43(3):427-33. PubMed ID: 8095694
    [Abstract] [Full Text] [Related]

  • 11. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M, White FJ.
    Synapse; 1989 Mar 04; 4(4):267-80. PubMed ID: 2603146
    [Abstract] [Full Text] [Related]

  • 12. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors.
    Meller E, Hizami R, Kreuter L.
    Pharmacol Biochem Behav; 1989 Jan 04; 32(1):141-5. PubMed ID: 2567521
    [Abstract] [Full Text] [Related]

  • 13. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
    Takano Y, Yaksh TL.
    J Pharmacol Exp Ther; 1991 Aug 04; 258(2):438-46. PubMed ID: 1678011
    [Abstract] [Full Text] [Related]

  • 14. Receptor reserve and turnover of alpha-2 adrenoceptors that mediate the clonidine-induced inhibition of rat locus coeruleus neurons in vivo.
    Pineda J, Ruiz-Ortega JA, Ugedo L.
    J Pharmacol Exp Ther; 1997 May 04; 281(2):690-8. PubMed ID: 9152374
    [Abstract] [Full Text] [Related]

  • 15. Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity.
    Meller E, Enz A, Goldstein M.
    Eur J Pharmacol; 1988 Oct 11; 155(1-2):151-4. PubMed ID: 2907486
    [Abstract] [Full Text] [Related]

  • 16. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1989 Oct 11; 44(15):1019-26. PubMed ID: 2564615
    [Abstract] [Full Text] [Related]

  • 17. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
    Mestlin M, McDougall SA.
    Pharmacol Biochem Behav; 1993 Aug 11; 45(4):797-802. PubMed ID: 8105488
    [Abstract] [Full Text] [Related]

  • 18. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
    Bohmaker K, Puza T, Goldstein M, Meller E.
    J Pharmacol Exp Ther; 1989 Jan 11; 248(1):97-103. PubMed ID: 2563295
    [Abstract] [Full Text] [Related]

  • 19. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
    McDougall SA, Crawford CA, Nonneman AJ.
    Psychopharmacology (Berl); 1992 Jan 11; 106(4):502-10. PubMed ID: 1349753
    [Abstract] [Full Text] [Related]

  • 20. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
    Ekman A, Eriksson E.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug 11; 346(2):152-7. PubMed ID: 1360151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.